• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植患者模式识别受体反应性筛查:实现个性化和精准器官匹配以降低缺血再灌注损伤风险的潜力。

Pattern Recognition Receptor-reactivity Screening of Liver Transplant Patients: Potential for Personalized and Precise Organ Matching to Reduce Risks of Ischemia-reperfusion Injury.

机构信息

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.

Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA.

出版信息

Ann Surg. 2020 May;271(5):922-931. doi: 10.1097/SLA.0000000000003085.

DOI:10.1097/SLA.0000000000003085
PMID:30480558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6620163/
Abstract

OBJECTIVE AND BACKGROUND

Pattern recognition receptors (PRRs) on immune and parenchymal cells can detect danger-associated molecular patterns (DAMPs) released from cells damaged during ischemia-reperfusion injury (IRI), in heart attack or stroke settings, but also as an unavoidable consequence of solid organ transplantation. Despite IRI being a significant clinical problem across all solid organ transplants, there are limited therapeutics and patient-specific diagnostics currently available.

METHODS

We screened portal blood samples obtained from 67 human liver transplant recipients both pre- [portal vein (PV) sample] and post-(liver flush; LF) reperfusion for their ability to activate a panel of PRRs, and analyzed this reactivity in relation to biopsy-proven IRI.

RESULTS

PV samples from IRI+ orthotopic liver transplantation (OLT) patients (n = 35) decreased activation of hTLR4- and hTLR9-transfected cells, whereas PV from IRI- patients (n = 32) primarily increased hTLR7 and hNOD2 activation. LF samples from OLT-IRI patients significantly increased activation of hTLR4 and hTLR9 over IRI- LF. In addition, the change from baseline reactivity to hTLR4/9/NOD2 was significantly higher in IRI+ than IRI- OLT patients.

CONCLUSIONS

These results demonstrate that TLR4/7/9 and NOD2 are involved in either promoting or attenuating hepatic IRI, and suggest a diagnostic screening of portal blood for reactivity to these PRRs might prove useful for prediction and/or therapeutic intervention in OLT patients before transplantation.

摘要

目的和背景

免疫细胞和实质细胞上的模式识别受体(PRRs)可以检测到在缺血再灌注损伤(IRI)、心脏病发作或中风情况下受损细胞释放的危险相关分子模式(DAMPs),但也作为实体器官移植不可避免的后果。尽管 IRI 是所有实体器官移植中一个重要的临床问题,但目前可用的治疗方法和针对患者的诊断方法有限。

方法

我们对 67 名接受肝移植的患者的门静脉血样进行了筛查,这些血样分别在再灌注前(门静脉样本)和再灌注后(肝脏冲洗;LF)获得,以检测其激活一组 PRRs 的能力,并分析这种反应与活检证实的 IRI 之间的关系。

结果

来自 IRI+原位肝移植(OLT)患者(n=35)的 PV 样本降低了 hTLR4 和 hTLR9 转染细胞的激活,而来自 IRI-患者(n=32)的 PV 样本主要增加了 hTLR7 和 hNOD2 的激活。OLT-IRI 患者的 LF 样本显著增加了 hTLR4 和 hTLR9 的激活,超过了 IRI-LF。此外,与 IRI-OLT 患者相比,IRI+OLT 患者的 hTLR4/9/NOD2 基线反应性的变化显著更高。

结论

这些结果表明,TLR4/7/9 和 NOD2 参与促进或减轻肝 IRI,并且提示对门静脉血中这些 PRRs 的反应进行筛查可能有助于在移植前预测和/或干预 OLT 患者。

相似文献

1
Pattern Recognition Receptor-reactivity Screening of Liver Transplant Patients: Potential for Personalized and Precise Organ Matching to Reduce Risks of Ischemia-reperfusion Injury.肝移植患者模式识别受体反应性筛查:实现个性化和精准器官匹配以降低缺血再灌注损伤风险的潜力。
Ann Surg. 2020 May;271(5):922-931. doi: 10.1097/SLA.0000000000003085.
2
Early cytokine signatures of ischemia/reperfusion injury in human orthotopic liver transplantation.原位肝移植中缺血/再灌注损伤的早期细胞因子特征。
JCI Insight. 2016 Dec 8;1(20):e89679. doi: 10.1172/jci.insight.89679.
3
Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.受体T细胞TIM-3和肝细胞半乳糖凝集素-9信号通路可保护小鼠肝移植免受缺血再灌注损伤。
J Hepatol. 2015 Mar;62(3):563-72. doi: 10.1016/j.jhep.2014.10.034. Epub 2014 Oct 31.
4
Native macrophages genetically modified to express heme oxygenase 1 protect rat liver transplants from ischemia/reperfusion injury.经基因改造表达血红素加氧酶 1 的天然巨噬细胞可保护大鼠肝移植免受缺血/再灌注损伤。
Liver Transpl. 2011 Feb;17(2):201-10. doi: 10.1002/lt.22214.
5
Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury.YAP 的激活可减轻肝缺血再灌注损伤中的肝损伤和纤维化。
J Hepatol. 2019 Oct;71(4):719-730. doi: 10.1016/j.jhep.2019.05.029. Epub 2019 Jun 13.
6
Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model.在小鼠肝移植模型中,供体器官中Toll样受体4(TLR4)信号的缺失可减轻缺血再灌注损伤。
Liver Transpl. 2007 Oct;13(10):1435-43. doi: 10.1002/lt.21251.
7
Endothelial YAP/TEAD1-CXCL17 signaling recruits myeloid-derived suppressor cells against liver ischemia-reperfusion injury.内皮细胞YAP/TEAD1-CXCL17信号通路招募髓源性抑制细胞以对抗肝脏缺血再灌注损伤。
Hepatology. 2025 Mar 1;81(3):888-902. doi: 10.1097/HEP.0000000000000773. Epub 2024 Feb 26.
8
Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity.病毒白细胞介素-10基因转移可预防肝脏缺血再灌注损伤:天然免疫和适应性免疫中的Toll样受体4和血红素加氧酶-1信号通路
Hum Gene Ther. 2007 Apr;18(4):355-66. doi: 10.1089/hum.2007.181.
9
Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation.二硫键-HMGB1 通过 TLR4 和 TLR9 信号诱导炎症性巨噬细胞,使其能够在人肝移植中进行先天-适应性串扰。
Am J Transplant. 2023 Dec;23(12):1858-1871. doi: 10.1016/j.ajt.2023.08.002. Epub 2023 Aug 9.
10
Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway.内源性危险信号通过Toll样受体4/核因子-κB途径引发肝脏缺血/再灌注损伤。
Chin Med J (Engl). 2007 Mar 20;120(6):509-14.

引用本文的文献

1
Chemoproteogenomic stratification of the missense variant cysteinome.错义变异半胱氨酸组的化学蛋白质基因组分层分析。
Nat Commun. 2024 Oct 28;15(1):9284. doi: 10.1038/s41467-024-53520-x.
2
Myeloid spatial and transcriptional molecular signature of ischemia-reperfusion injury in human liver transplantation.人类肝移植中缺血再灌注损伤的髓样空间和转录分子特征。
Hepatol Commun. 2024 Jan 11;8(1). doi: 10.1097/HC9.0000000000000330. eCollection 2024 Jan 1.
3
Immune Features of Disparate Liver Transplant Outcomes in Female Hispanics With Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎女性西班牙裔患者肝移植不同结局的免疫特征
Transplant Direct. 2023 Oct 20;9(11):e1550. doi: 10.1097/TXD.0000000000001550. eCollection 2023 Nov.
4
Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation.二硫键-HMGB1 通过 TLR4 和 TLR9 信号诱导炎症性巨噬细胞,使其能够在人肝移植中进行先天-适应性串扰。
Am J Transplant. 2023 Dec;23(12):1858-1871. doi: 10.1016/j.ajt.2023.08.002. Epub 2023 Aug 9.
5
New therapeutic concepts against ischemia-reperfusion injury in organ transplantation.器官移植中对抗缺血再灌注损伤的新治疗概念。
Expert Rev Clin Immunol. 2023 Jul-Dec;19(10):1205-1224. doi: 10.1080/1744666X.2023.2240516. Epub 2023 Jul 28.
6
Molecular Mechanisms of Ischaemia-Reperfusion Injury and Regeneration in the Liver-Shock and Surgery-Associated Changes.肝缺血再灌注损伤和再生的分子机制-休克和手术相关变化。
Int J Mol Sci. 2022 Oct 26;23(21):12942. doi: 10.3390/ijms232112942.
7
Salidroside alleviates hepatic ischemia-reperfusion injury during liver transplant in rat through regulating TLR-4/NF-κB/NLRP3 inflammatory pathway.红景天苷通过调控 TLR-4/NF-κB/NLRP3 炎症通路减轻大鼠肝移植肝缺血再灌注损伤。
Sci Rep. 2022 Aug 17;12(1):13973. doi: 10.1038/s41598-022-18369-4.
8
Liver ischaemia-reperfusion injury: a new understanding of the role of innate immunity.肝脏缺血再灌注损伤:固有免疫作用的新认识。
Nat Rev Gastroenterol Hepatol. 2022 Apr;19(4):239-256. doi: 10.1038/s41575-021-00549-8. Epub 2021 Nov 26.
9
New Insights in Mechanisms and Therapeutics for Short- and Long-Term Impacts of Hepatic Ischemia Reperfusion Injury Post Liver Transplantation.肝移植术后肝缺血再灌注损伤的短期和长期影响的机制和治疗的新见解。
Int J Mol Sci. 2021 Jul 30;22(15):8210. doi: 10.3390/ijms22158210.
10
The Potential Application of Magnetic Nanoparticles for Liver Fibrosis Theranostics.磁性纳米颗粒在肝纤维化诊疗中的潜在应用
Front Chem. 2021 May 14;9:674786. doi: 10.3389/fchem.2021.674786. eCollection 2021.

本文引用的文献

1
Normothermic machine perfusion of the liver.肝脏常温机器灌注
Clin Liver Dis (Hoboken). 2017 Oct 31;10(4):97-99. doi: 10.1002/cld.661. eCollection 2017 Oct.
2
Endoscopic Ultrasound-guided Portal Venous Access: Diagnostic and Therapeutic Implications.内镜超声引导下门静脉穿刺:诊断与治疗意义
J Clin Gastroenterol. 2017 Sep;51(8):677-682. doi: 10.1097/MCG.0000000000000897.
3
Early cytokine signatures of ischemia/reperfusion injury in human orthotopic liver transplantation.原位肝移植中缺血/再灌注损伤的早期细胞因子特征。
JCI Insight. 2016 Dec 8;1(20):e89679. doi: 10.1172/jci.insight.89679.
4
Normothermic Machine Perfusion of Deceased Donor Liver Grafts Is Associated With Improved Postreperfusion Hemodynamics.已故供体肝脏移植物的常温机器灌注与改善再灌注后血流动力学相关。
Transplant Direct. 2016 Aug 5;2(9):e97. doi: 10.1097/TXD.0000000000000611. eCollection 2016 Sep.
5
Portal-vein blood samples as a new diagnostic entity for pancreatic cancer.门静脉血样本作为胰腺癌的一种新的诊断实体。
Expert Rev Gastroenterol Hepatol. 2016 Jun;10(6):665-7. doi: 10.1080/17474124.2016.1176911. Epub 2016 May 3.
6
Past, Present, and Future of Dynamic Kidney and Liver Preservation and Resuscitation.动态肾脏和肝脏保存与复苏的过去、现在和未来
Am J Transplant. 2016 Sep;16(9):2545-55. doi: 10.1111/ajt.13778. Epub 2016 Apr 1.
7
Liver Transplantation After Ex Vivo Normothermic Machine Preservation: A Phase 1 (First-in-Man) Clinical Trial.体外常温机器保存后的肝移植:一项1期(首例人体)临床试验。
Am J Transplant. 2016 Jun;16(6):1779-87. doi: 10.1111/ajt.13708. Epub 2016 Mar 7.
8
Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion.体外常温机器灌注期间废弃人类供肝生存能力评估标准
PLoS One. 2014 Nov 4;9(11):e110642. doi: 10.1371/journal.pone.0110642. eCollection 2014.
9
Nucleic acid sensing and beyond: virtues and vices of high-mobility group box 1.核酸感应及其他:高迁移率族蛋白 B1 的优缺点。
J Intern Med. 2014 Nov;276(5):444-53. doi: 10.1111/joim.12285.
10
"Resuscitation" of marginal liver allografts for transplantation with machine perfusion technology.使用机器灌注技术对边缘供肝进行再灌注以用于移植。
J Hepatol. 2014 Aug;61(2):418-31. doi: 10.1016/j.jhep.2014.04.019. Epub 2014 Apr 24.